Growth of the Respiratory Care Devices Market

The respiratory care devices market is projected to expand significantly, increasing from US$ 18,114.31 million in 2021 to US$ 32,761.82 million by 2028. This growth represents a compound annual growth rate (CAGR) of 8.9% over the period from 2021 to 2028.

Market Trends and Drivers

This report outlines the prevailing trends and key factors propelling the growth of the respiratory care devices market. The surge in market growth can be attributed to several factors, including:

• Increasing incidence of infectious respiratory diseases.


• Rising cases of asthma and chronic obstructive pulmonary disease (COPD).


• Growing number of product launches and regulatory approvals.


• Increased investment in research and development for respiratory care devices.

Despite these positive trends, the market faces challenges such as intense competition among manufacturers and unfavorable reimbursement conditions, which may hinder growth.

Overview of Respiratory Care Devices

Respiratory care devices are designed to assist patients in managing respiratory conditions. Common devices in this category include:

• Oxygen concentrators


• Ventilators


• Nebulizers


• Inhalers


• Positive airway pressure (PAP) devices


• Spirometers

These devices serve various functions, including therapeutic, diagnostic, and monitoring purposes.

Rising Incidence of Asthma and COPD

The increase in chronic respiratory diseases (CRDs) significantly impacts the demand for respiratory care devices. CRDs, which include asthma and COPD, affect the airways and lung structures. Symptoms of these conditions often overlap with those of COVID-19, leading to a heightened reliance on respiratory devices. A study published in the Journal of Allergy and Clinical Immunology noted that adherence to inhaler medications among COPD and asthma patients increased during the COVID-19 pandemic. Furthermore, the National Health Service (NHS) reported a 63% rise in inhaler prescriptions in England from February to March 2020, highlighting the increased demand for these devices.

Asthma, a prevalent non-communicable disease, affects individuals of all ages and is on the rise due to factors such as allergic reactions to environmental allergens and pollution. Key statistics include:

• According to the WHO, asthma affected approximately 262 million people globally in 2019, resulting in 4.5 million deaths.


• The UK saw a 33% increase in asthma-related deaths from 2008 to 2018, as reported by the British Medical Journal.


• In the US, around 25 million individuals have asthma, equating to 1 in every 13 people, according to the Asthma and Allergy Foundation of America.


• Asthma prevalence is higher in male children, with 3.3% affected compared to 1.6% of female children, as per the AAFA.


• Secondhand smoke exposure is linked to increased asthma attacks in children, according to the CDC.

COPD, characterized by persistent airflow limitation and lung elasticity loss, is another major contributor to the demand for respiratory devices. The The Lancet reported a global COPD prevalence of 10.3% in 2019, translating to 391.9 million cases among individuals aged 30-79. COPD is the third leading cause of death worldwide, responsible for 3.23 million deaths in 2019. The American Society of Health-System Pharmacists identifies four primary device types for delivering COPD medications: pressurized metered-dose inhalers (pMDI), dry powder inhalers (DPI), soft mist inhalers (SMI), and nebulizers.

Market Insights

The global respiratory care devices market is categorized by product type, indications, end users, and geographical regions. The product segments include:

• Therapeutic devices


• Monitoring devices


• Diagnostic devices


• Consumables & accessories

The therapeutic devices segment dominated the market in 2021 and is expected to maintain the highest growth rate during the forecast period. In terms of indications, the market is divided into COPD, sleep apnea, asthma, infectious diseases, and others, with COPD holding the largest market share in 2021.

By end user, the market is segmented into hospitals, home care, and ambulatory care, with hospitals leading in market share. Geographically, the market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share in 2021, while the Asia Pacific region is anticipated to exhibit the highest growth rate in the coming years.

Key sources for this report include the World Health Organization (WHO), Pan American Health Organization (PAHO), Centers for Disease Control and Prevention (CDC), and various health journals and organizations.